This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Alert me to new issues of the journal
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld

A Replication-Limited Recombinant Mycobacterium bovis BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG
Infect. Immun. Tullius et al. 76: 5200

Supplemental material

Files in this Data Supplement:

  • Supplemental file 1 - Table S1. Sequences of primers used in this study.
    MS Word document, 34K.
  • Supplemental file 2 - Supplemental methods. Further details of the construction of BCG mbtB, BCG panCD, and BCG trpD mutants.
    MS Word document, 48K.
  • Supplemental file 3 - Fig. S1. Complementation of BCG mutants.
    Zipped EPS file, 832K.



This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Alert me to new issues of the journal
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»